Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling.
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushTWIST1 and BMI1 in Cancer Metastasis and ChemoresistanceCancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic StrategiesMesenchymal Stem Cell-Mediated Effects of Tumor Support or SuppressionDifferentiation and transdifferentiation potentials of cancer stem cellsMultiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancerEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachInteraction of MSC with tumor cellsEpithelial-Mesenchymal Plasticity: A Central Regulator of Cancer ProgressionIdentifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discoveryStemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerMicroenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Somatic mutations in leukocytes infiltrating primary breast cancers.Fibroblast heterogeneity in the cancer wound.Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevanceBone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesThe epigenetics of epithelial-mesenchymal plasticity in cancer.Tackling the cancer stem cells - what challenges do they pose?Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models.A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell deathDisequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response.Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas.Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancerEpigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell linesRegulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathwayThe potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progressionPhysical Intimacy of Breast Cancer Cells with Mesenchymal Stem Cells Elicits Trastuzumab Resistance through Src ActivationExogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay.Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published StudiesHeterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis.
P2860
Q26741215-1503DD1E-1514-4A1D-97F4-394DE3F1D716Q26744196-C19E32DE-0FF1-408B-89ED-9EDCB08001EBQ26765342-D3012DB5-CA51-435A-BC39-76B580DF2E50Q26773413-2B840A74-6599-4C58-9F50-C9D27593398AQ26782242-93604F7C-044E-498F-9AFC-C8143E03A0C9Q26828414-9C151094-1324-4A7F-B461-9808EA50D255Q26849477-1CDC0308-F559-4B62-9A12-74DEC508FC8CQ28074526-E5D49227-A666-494C-806C-901DEA54EE3CQ28081012-710B1741-E134-492A-B12C-23307905C2FEQ28540918-9FE4656B-F236-4857-9239-BE086DDC4466Q33572252-A1BFEFEE-2132-4475-B6CC-8565F1A85864Q33688897-C3E984A0-F2FD-4CE3-9C93-14B517AA8D16Q33760216-4D71AA91-3033-4076-BF81-D0AB5B2053AFQ33786788-638E4C05-41D0-41FA-A64F-95AB121A1FD3Q33914716-20D29E54-5893-4715-8DFC-EA30F62A44EFQ33964324-5442E8C2-AE5C-43D9-8888-AB04C1F421E8Q33975619-C042AD8E-6A03-4490-97A8-88A4740D534CQ34132305-68E28C1C-2394-4BE6-8447-32AEAC2842AAQ34310378-4D1CC07C-585F-4891-9101-E8D4DE0FC345Q34523263-CE998A6E-EDAC-4648-8217-7741C7715123Q34874275-023C0CFD-955C-4ABC-BFFF-0F68AA682282Q34975953-2FFF3C2E-EF40-41E4-94F3-3FEBD98C7F99Q34985576-843BBA44-7FDE-4274-B2A5-9A44FEA89C42Q35037638-AEBB6C21-7C03-48EE-935D-5A22F241E5C6Q35068689-BFE18290-1D97-4660-BBDE-C0B86BD40D1FQ35075436-98EB82A3-7204-42E2-959E-012ACF467826Q35112364-81798E2A-5D9B-42C2-BDFC-B9FFE034343EQ35352078-4EAB7416-E7E9-4BDF-9E13-3D1E88CC61C4Q35578981-44E6A8D0-B745-48F0-8C62-1CA6080C114BQ35586175-BFF28F7A-530B-4496-839C-FF6BB96D4BADQ35748219-884CBE88-2EC5-45EF-91C5-4DB925937D3FQ35790286-9E1E03F1-D1E6-4A8C-B77B-577FC16B85DCQ35818767-EEE1FD23-2460-4D15-AB0D-727837DA4039Q35831031-3E4E30D5-5951-4342-8372-FF0362D2AC2AQ36021066-BFA4CB69-435B-4306-A16F-17C56391363FQ36034029-87F9431E-9DF5-4D15-B919-60D6C89C5381Q36082553-FA840754-DDBD-48B3-AAF6-82F43AFC24E9Q36086002-B195EC66-0BBB-4CFA-8CA1-2A865C580D80Q36165598-F30C8CDB-B244-4F0B-BBC5-0D764F435E94Q36444308-7796EEAD-AB65-4EC5-845F-CE2ED9889BB3
P2860
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@en
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@nl
type
label
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@en
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@nl
prefLabel
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@en
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@nl
P2860
P1433
P1476
Cancer-stimulated mesenchymal ...... ia prostaglandin E2 signaling.
@en
P2093
Harvey R Herschman
Hua-Jung Li
P2860
P304
P356
10.1158/2159-8290.CD-12-0101
P577
2012-07-03T00:00:00Z